Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Efficacy shown for ISTA's tobramycin / prednisolone acetate combination product

Feb. 6, 2006

CombinatoRx and Fovea to develop novel ophthalmic therapeutics

Feb. 3, 2006

Novel ophthalmic compounds described by Alcon in a recent patent

Feb. 2, 2006

Xibrom approved for treatment of pain following cataract surgery

Feb. 1, 2006

Alpha-defensin treatment for proliferative retinopathy that complicates diabetes and prematurity

Jan. 30, 2006

Pfizer updates Canadian safety information for Macugen

Jan. 26, 2006

Tosufloxacin tosilate ophthalmic solution approved in Japan

Jan. 25, 2006

Inspire discontinues development of denufosol tetrasodium for retinal diseases

Jan. 25, 2006

Recent patent discloses novel therapeutic agents for ocular disorders

Jan. 20, 2006

Positive toxicology data for Binoxan active ingredient

Jan. 20, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...